Endotoxin: Clinical Trials

2 trials of Endotoxin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2
Phase 21Completed 1

Follow Endotoxin: new trials by email Literature Review of Endotoxin trials Research Report on Endotoxin

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Innate Central Nervous System Immune Response to an Experimental Immune Challenge in People With Fibromyalgia
Endotoxin, Escherichia Coli, Magnetic Resonance Spectroscopy - Fibromyalgia
Phase 2 / Phase 3CompletedUniversity of Alabama at Birmingham362020-03-112023-04-14
In Vivo Effects of C1-esterase Inhibitor on the Innate Immune Response During Human Endotoxemia - VECTOR II
C1-esterase inhibitor, Endotoxin - Innate Immune Response, Endotoxemia
Phase 3CompletedRadboud University Medical Center202013-09-012014-12-02

Conditions studied

Chronic Pain (1)  ·  Endotoxemia (1)  ·  Fibromyalgia (1)  ·  Inflammation (1)  ·  Neuroinflammatory Diseases (1)  ·  Sepsis (1)

Sponsors

Radboud University Medical Center (1)  ·  University of Alabama at Birmingham (1)

Countries

Netherlands (1)  ·  United States (1)

Top investigators

Hans Hoeven, Prof (1)  ·  Jarred M Younger, PhD (1)

Results publications

PMID 28515092